title: The Sézary syndrome: hematologic criteria.
abstract: The hematologic criteria for Sézary syndrome that were recently proposed by the International Society on Cutaneous Lymphomas are critically evaluated. Based on the experience at two institutions, revisions to the definition for Sézary syndrome are proposed.
authors.affiliation: Department of Dermatology, Johns Hopkins Medical Institutions, 550 North Broadway, Suite 1002, Baltimore, MD 21205, USA. evonder1@jhmi.edu
authors.forename: Eric C
authors.initials: EC
authors.lastname: Vonderheid
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Bernengo
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D016516:CD4-CD8 Ratio; D002999:Clone Cells / Q000473:pathology; D003873:Dermatitis, Exfoliative / Q000209:etiology; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating; D014411:Neoplastic Stem Cells / Q000473:pathology; D012751:Sezary Syndrome / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D012878:Skin Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor